Skip to main content
Premium Trial:

Request an Annual Quote

Brian Ward, Stella Quan, Stefan Mllner, Christoph Hls

Premium
The DNA Repair Company has appointed Brian Ward as executive vice president and named Stella Quan senior director of product development.
 
Ward formerly was senior VP for Genomic Health. He also has served as president of medical genetic services and senior vice president of operations at Myriad Genetic Laboratories, and he has worked at Genzyme Genetics and at the University of Colorado.
 
Quan was director of immunoassay development for bioMérieux, was senior director of operations at Tripath Oncology, and was involved in research and development at Chiron.
 

 
Stefan Müllner has been named the new CEO of Protagen, succeeding Christoph Hüls, who is leaving the firm to join an unnamed pharmaceutical company. Müllner has been the firm's chief scientific officer.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.